03.09.2012 • News

Business Monitor International Aquires Espicom Business Intelligence

Business Monitor International, a provider of country risk, financial markets and industry research across global markets, has announced the acquisition of Espicom Business Intelligence, a UK-based company with a 30-year pedigree providing business intelligence on Medical Devices, Pharmaceuticals & Healthcare and Therapeutics across global markets.

The financial terms of the transaction have not been disclosed.

The acquisition brings to BMI Espicom's wide-range of information and business intelligence services for the global healthcare industries. In medical technology and devices, Espicom's service features coverage of key operators in 70 country markets, proprietary 5-year forecasts, daily news on key technologies and critical management reports on areas such as advanced wound care, diagnostic products and market access. In pharmaceuticals, Espicom's service features country-level data, therapeutics, generics and biosimilars markets coverage and specialized drug development database services.

 

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.